Renaissance Technologies - GT BIOPHARMA INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q3 2023$16
-44.8%
66,700
-27.6%
0.00%
Q2 2023$29
-23.7%
92,181
+32.8%
0.00%
Q1 2023$38
-7.3%
69,400
+50.2%
0.00%
Q4 2022$41
-100.0%
46,200
-28.6%
0.00%
Q2 2022$193,000
-64.1%
64,701
-65.3%
0.00%
-100.0%
Q1 2022$537,000
-42.6%
186,300
-39.3%
0.00%0.0%
Q4 2021$935,000
+63.7%
306,700
+262.1%
0.00%0.0%
Q3 2021$571,00084,7000.00%
Other shareholders
GT BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$470.01%
McCollum Christoferson Group LLC 17,500$5,4600.00%
Moss Adams Wealth Advisors LLC 10,000$3,1200.00%
JANE STREET GROUP, LLC 20,501$6,3960.00%
Cubist Systematic Strategies, LLC 10,458$3,2630.00%
Point72 Asset Management, L.P. 1$00.00%
UBS Group AG 3,033$9460.00%
Compagnie Lombard Odier SCmA 50,000$15,6000.00%
IFP Advisors, Inc 100$2750.00%
OSAIC HOLDINGS, INC. 1,017$3160.00%
View complete list of GT BIOPHARMA INC shareholders